Bulls vs Bears
Click to unlock major analysts' bullish and bearish positions by joining Benzinga Edge.
Dynavax Technologies Stock (NASDAQ: DVAX) stock price, news, charts, stock research, profile.
Open | - |
Close | - |
Volume / Avg. | 0 / 2.26M |
Day Range | - - - |
52 Wk Range | 9.74 - 15.15 |
Market Cap | $1.46B |
P/E Ratio | 85.46 |
Dividend Yield | - |
Exchange | NASDAQ |
RSI | 49 |
Short Interest | 17.06% |
Days to Cover | 10.83 |
Name |
---|
Revenue Change |
Gross Change |
EBITDA Change |
EBIT Change |
Earnings Change |
You can purchase shares of Dynavax Technologies (NASDAQ:DVAX) through any online brokerage.
Other companies in Dynavax Technologies’s space includes: ARS Pharmaceuticals (NASDAQ:SPRY), Gyre Therapeutics (NASDAQ:GYRE), Centessa Pharmaceuticals (NASDAQ:CNTA), Syndax Pharmaceuticals (NASDAQ:SNDX) and Immatics (NASDAQ:IMTX).
Dynavax Technologies has a consensus price target of $23.00.
The stock price for Dynavax Technologies (NASDAQ: DVAX) is $11.11 last updated September 23, 2024 at 4:00 PM EDT.
There are no upcoming dividends for Dynavax Technologies.
Dynavax Technologies’s Q3 earnings are confirmed for Thursday, October 31, 2024.
There is no upcoming split for Dynavax Technologies.
Dynavax Technologies is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.